Status
Conditions
Treatments
About
Full description
Cancer-related lymphedema represents one of the major complications of cancer treatment, especially for breast and gynecologic cancers. Moreover, it has high impact on cancer survivors and healthcare systems. Lymphedema management still remains challenging. The better understanding of lymphedema physiopathology as well as the development of sophisticated surgical and diagnostic techniques have led to effective strategies to address lymphedema patients but, despite the considerable interest in international literature, no consensus exist. The combination of LVA and liposuction may represent an effective strategy in treating patients with cancer-related lymphedema, in order to reach a significant decrease in volume and reduction of lymphangitis rate as well as stable results in time. In addition, it has the aim of being minimally invasive and well tolerated by patients
Enrollment
Sex
Ages
Volunteers
Inclusion and exclusion criteria
Inclusion Criteria: patients affected by secondary lymphedema
Exclusion Criteria:
persistence of the neoplastic pathology
patients affected by primary lymphedema
24 participants in 1 patient group
Loading...
Central trial contact
Guido Gabriele, MD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal